Early Access — free while we kick the tires
EdgarHawk

Millner F. Ann

Director

Director
3 filings analyzed · 1 company · Latest 2025-05-19

Companies

Company Buys Sells Direction
MERIT MEDICAL SYSTEMS INC MMSI 0 8 Net selling

Activity

May 2025
medium
Sell
21,250 shares
$2,049,988
Significance 5/10

Director Ann Millner sold 21,250 shares of MMSI at $96.47 for $2.0M, reducing stake by 38.1% to 34,543 shares; stock now -11.0% from 52-week high.

Millner divested a substantial portion of her MMSI holdings, selling 21,250 shares at $96.47 on 2025-05-15 and retaining 34,543 shares post-transaction. Across her same-ticker history at MMSI, prior sells on 2024-11-15 and 2024-06-28 delivered positive 30-day and 90-day returns (the latter posting 30d +0.6%, 90d +14.8%), while only 1 of 4 prior same-ticker sales were well-timed at the 90-day mark. Her cross-ticker track record shows a 25.00% well-timed rate on sells, slightly above random, though the immediate 30-day outlook appears mixed: the stock gained 7.9% in the 30 days following this filing date, and currently trades at $98.10, implying the executed price of $96.47 was within the intermediate range. The company carries a P/E of 47.39 and generated $355.4M in revenue with $30.1M net income last quarter, underpinning a $5.8B market cap, though annual revenue growth of +7.9% leaves open questions about whether valuation reflects growth expectations.

November 2024
medium
Sell
12,500 shares
$1,269,375
Significance 5/10

Director Ann F. Millner sold 12,500 shares of MMSI at $101.55 on 2024-11-15, reducing stake from 44,891 to 32,391 shares (-27.8%).

Director Ann F. Millner sold 12,500 shares at $101.55, representing a -27.8% reduction in her holdings and generating $1,269,375.00 in proceeds. The sale occurred when MMSI was trading near its 52-week high of $104.24 (current price $103.94), and at 30-day and 90-day momentum indicators of +7.7% and +14.3% respectively, suggesting she sold into strength. Across her prior three same-ticker sales at MMSI, only one of three exhibited a negative 90-day return (the 2024-01-22 sell with -10.0%), indicating mixed timing on this security historically. The company's fundamentals show healthy revenue of $339,845,000.00, net income of $28,444,000.00, and annual growth of +9.2%, though the P/E of 50.46 reflects a premium valuation that may constrain upside.

July 2024
high
Sell
12,500 shares
$1,062,500
Significance 6/10

Director Millner sells 12,500 shares at $85.00 for $1,062,500.00, reducing stake by 27.8%.

Millner F. Ann, a director at Merit Medical Systems, executed 2 separate sales totaling 12,500 shares for $1,062,500.00 at $85.00/share on 2024-06-28, reducing her holdings from 44,891 to 32,391 shares. Her prior sell at this same ticker (2024-01-22) showed negative 90-day returns, and her cross-ticker track record demonstrates a 100% well-timed rate on sells—suggesting a pattern of exiting ahead of declines. The current stock price stands at $86.50, just 1.8% above the transaction price, and the stock has rallied 18.7% over the prior 90 days and 6.6% over the prior 30 days. The magnitude of the sale (27.8% of pre-transaction holdings) represents a material reduction in her position during a period of strong price momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access